Effect of acute administration of hypericum perforatum-CO2 extract on dopamine and serotonin release in the rat central nervous system

Pharmacopsychiatry

Volumn 33, Issue 1, 2000, Pages 14-18

  Di Matteo, V ^a   Di Giovanni, G ^a   Di Mascio, M ^a   Esposito, Ennio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HYPERICUM PERFORATUM EXTRACT; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEPRESSION; DOPAMINE RELEASE; DRUG MECHANISM; HERBAL MEDICINE; HIPPOCAMPUS; MENTAL DISEASE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; TRADITIONAL MEDICINE;

EID: 0033950831     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-8449     Document Type: Article

References (26)

1. 1 Bourin M, Baker GB: The future of antidepressants. Biomed Pharmacother. 1996; 50: 7-12
2. 2 Brolis M, Gabetta R, Fuzzati N, Pace R, Panzeri F, Peterlongo F: Identification by high-performance liquid chromatography-diode array detection-mass spectrometry and quantification by high-performance liquid chromatography-UV absorbance detection of active constituents of Hypericum perforatum. J Chromatogr. 1998; 825: 9-16
3. 3 Brown AS, Gershon S: Dopamine and depression. J Neural Transm Gen Sec. 1993; 91: 75-109
4. 4 Butterweck V, Wall A, Liefländer-Wulf U, Winterhoff H, Nahrstedt A: Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity. Pharmacopsychiatry. 1997; 30 (Supp. 2): 117-124
5. 5 Cabib S, Puglisi-Allegra S: Stress, depression and the mesolimbic dopamine system. Psychopharmacology. 1996; 128: 331-342
6. 6 Cervo L, Grignaschi G, Samanin R: The role of the mesolimbic dopaminergic system in the desipramine effect in the forced swimming test. Eur J Pharmacol. 1990; 178: 129-133
7. 7 Cervo L, Samanin R: Repeated treatment with imipramine and amitriptyline reduced the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens. J Pharm Pharmacol. 1988, 40: 155-156
8. 8 Cervo L, Samanin R: Evidence that dopamine mechanisms in the nucleus accumbens are selectively involved in the effect of desipramine in the forced swimming test. Neuropharmacology. 1987; 26: 1469-1472
9. 9 Chatterjee SS, Bhattacharya SK, Singer A, Müller WE: Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci. 1998; 63: 499-510
10. 10 De Montis GM, Devoto P, Gessa L, Meloni D, Porcella A, Saba P, Serra G, Tagliamonte A: Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur J Pharmacol. 1990; 180: 31-35
11. 11 De Smet PAGM, Nolen WA: 1996 St John's wort as an antidepressant. Br Med J. 1996; 313: 241-242
12. 12 Fibiger HC: Neurobiology of depression: focus on dopamine. In: Gessa G, Fratta W, Pani L, Serra G, (Eds), Depression and mania: from neurobiology to treatment. Raven Press, New York, NY 1995: 1-17
13. 13 Fuller RW: Microdialysis studies with 5-HT reuptake inhibitors. Trends Pharmacol Sci. 1993; 14: 397-398
14. 14 Gambarana C, Ghiglieri O, Tolu P, De Montis MG, Giachetti D, Bombardelli E, Tagliamonte A: Efficacy of an Hypericum perforatum (St. John's Worth) extract in preventing and reverting a condition of escape deficit in rats. Neuropsychopharmacology 1999; 21: 247-257
15. 15 Kaehler ST, Sinner C, Chatterjee SS, Philippu A: Hyperforin enhances the extracellular concentrations of catecholamines, serotonin, and glutamate in the rat locus coeruleus. Neurosci Lett. 1999; 262: 199-202
16. 16 Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D: St John's wort for depression - an overview and meta-analysis of randomised clinical trials. Br Med J. 1996; 313: 253-258
17. 17 Moghaddam B, Bunney BS: Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. J Neurochem. 1989; 53: 652-654
18. 18 Müller WE, Rolli M, Schäfer C, Hafner U: Effects of Hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry. 1997; 30 (Suppl. 2): 102-107
19. 19 Müller WE, Singer A, Wonnemann U, Hafner U, Rolli M, Schäfer C: Hyperforin represents the neurotransmitter reuptake inhibiting constituent of Hypericum extract. Pharmacopsychiatry. 1998; 31 (Suppl. 1): 16-21
20. 20 Nahrstedt A, Butterweck V: Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry. 1997; 30 (Suppl. 2): 129-134
21. 21 Öztürk Y: Testing the antidepressant effects of Hypericum species on animal models. Pharmacopsychiatry. 1997; 30 (Suppl. 2): 125-128
22. 22 Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, NY 1986
23. 23 Plaznik A, Kostowski W: The effects of antidepressants and electroconvulsive shocks on the functioning of the mesolimbic dopaminergic system: a behavioral study. Eur J Pharmacol. 1987; 135: 389-396
24. 24 Puglisi-Allegra S, Imperato A, Angelucci L, Cabib S: Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res. 1991; 554: 217-222
25. 25 Richelson E: Synaptic effects of antidepressants. J Clin Psychopharmacol. 1996; (Suppl. 2) 16: 1S-7S
26. 26 Volz H-P: Controlled clinical trials of hypericum extracts in depressed patients - an overview. Pharmacopsychiatry. 1997; 30 (Suppl. 2): 72-76